Advertisement
Singapore markets closed

  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     

  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     

  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     

  • FTSE 100

    7,844.24
    -32.81 (-0.42%)
     

  • Bitcoin USD

    64,766.09
    +2,503.52 (+4.02%)
     

  • CMC Crypto 200

    1,337.55
    +24.93 (+1.94%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • Dow

    37,775.38
    +22.07 (+0.06%)
     

  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     

  • Gold

    2,394.60
    -3.40 (-0.14%)
     

  • Crude Oil

    82.20
    -0.53 (-0.64%)
     

  • 10-Yr Bond

    4.6040
    -0.0430 (-0.93%)
     

  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     

  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     

  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Ipsen to buy some Merrimack assets for about $1 billion

Reuters

(Reuters) - French drugmaker Ipsen SA (IPN.PA) said on Monday it would buy some assets of U.S. peer Merrimack Pharmaceuticals Inc (MACK.O), including its pancreatic cancer treatment Onivyde, for about $1 billion.

Ipsen will pay $575 million cash at the closing of the deal and up to $450 million more, contingent on some approvals for Onivyde in the United States.

Reuters reported the deal on Sunday, citing people familiar with the matter.

(Reporting by Ismail Shakil in Bengaluru; Editing by Peter Cooney)